Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Animal health industry

Animal health is a segment of the life sciences industry at the interface of pharmaceuticals and agrochemicals. Global sales were 15 billion in 2005 ( 14.5 billion in 2004, 13.8 billion in 2001, inflation-adjusted). Of the top 10 companies, 9 are business units or spinoffs from pharmaceutical companies (see Table 11.9). The industry is rather concentrated, with the top 10 companies accounting for 75% of total sales. As they do in pharma, US companies dominate in animal health products. Many of the veterinary products in the portfolios had originally been developed for human use or as pesticides. In the pet (respectively companion animal) segment, which comprises cats, dogs, birds, some rodents, reptiles, and horses and represents about 40% of the total market, the association with human health is particularly prominent. [Pg.106]

Rank Company/Division Sales (2005) ( billion) Parent Company [Pg.106]

4 Bayer Animal Health, Denmark 1.06 Bayer AG, Germany [Pg.106]

7 Schering-Plough Animal Health, USA 0.85 Schering-Plough, USA [Pg.106]

8 Novartis Animal Health, Switzerland 0.79 Novartis, Switzerland [Pg.106]


The Animal Health Institute (AHI), the premier trade organization of animal health industries, had its beginnings in Des Moines, Iowa, sharing offices and staff with the Iowa Pharmacists Association. The executive secretary of the Iowa Pharmaceutical Association and Animal Health Institute was a pharmacist who eventually became the full-time executive secretary for the AHI when it moved its headquarters to Washington, D.C. [Pg.723]

To assist the animal health industry, the FDA has developed a set of general guidelines that may be used as an acceptable basis for determining drug safety... [Pg.323]

The tetracyclines were discovered towards the end of the 1940 s (structure of oxytetracycline shown in Figure 5), They have a broader spectrum of activity than the early penicillins. In addition effects on bacteria are different. The penicillins are bactericidal whereas the tetracyclines are bacteriostatic, reflecting differing modes of action. Tetracyclines disrupt protein synthesis by binding to the bacterial ribosome whilst the P-lactams inhibit bacterial cell wall biosynthesis. During the 60 s, 70 s and early 80 s, tetracycline-based products made the biggest commercial impact in the animal health industry. [Pg.48]

A U.S. federal judge s injunction of the FDA s product tracking requirement is issued for secondary wholesalers. Animal health industry manufacturers embrace a global product identification standard. The pharmaceutical industry rushed to meet Turkey s serialization requirements for all products sold in the country. [Pg.277]

The scientific interest in cereal /1-glucans arose partly from the problems they cause in brewing and animal-feed industries in the case of barley [318] and partly from the health benefits, such as cholesterol reduction [319-321], regulation of postgrandial seriun glucose levels in humans and animals [319,322], and immunostimulatory activity [323,324]. Some of these activities have been observed with both oat and barley )6-glucans [325]. [Pg.39]

The ability to efficiently synthesize enantiomerically enriched materials is of key importance to the pharmaceutical, flavor and fragrance, animal health, agrochemicals, and functional materials industries [1]. An enantiomeric catalytic approach potentially offers a cost-effective and environmentally responsible solution, and the assessment of chiral technologies applied to date shows enantioselective hydrogenation to be one of the most industrially applicable [2]. This is not least due to the ability to systematically modify chiral ligands, within an appropriate catalyst system, to obtain the desired reactivity and selectivity. With respect to this, phosphorus(III)-based ligands have proven to be the most effective. [Pg.773]

In real terms, the growth of the animal health market has been just over 1%/year since the mid-1990s. Whereas the market in the developed world is almost saturated, a rapid increase in demand is expected in developing countries. Of 1.5 billion farm animals, 1 million are located in tropical and subtropical countries. Also, more and more of the latter are raised by industrial methods and require regular medication. Likewise, an increasing number of affluent people in these countries can afford lifestyle medicines for their pets. On a global basis, an annual growth between 1.5% and 2.0% is expected in the 2006-2010 period. [Pg.108]

The simplicity and convenience of this chemistry led to an industrial application on a large scale, as illustrated by the synthesis of Danofloxacin, an animal health quinolone antibiotic (equation 107). [Pg.499]

Veterinary diseases attract little government support for research. Animal health applications are typically cost-constrained by the economics of animal production. Consequently, the profit found in veterinary products is usually lower than in human pharmaceuticals, which draws industrial research investment away from animal health, including parasitology. [Pg.325]

Adams, D. B. Cobon, G. (1984). Basis for the development of vaccines for control of diseases produced by metazoan parasites. In Biotechnology and recombinant DNA technology in animal production industries, ed. J. C. Nugent M. O Connor, pp. 67-74. Reviews in Rural Science, no. 6. CSIRO Division of Animal Health Armidale, New South Wales. [Pg.305]

Vertex business is divided into six categories Technical Components, Dairy, Industrial Containers, Household Products, Food Trays and Securefresh. Processes include rigid blow-moulded containers for industrial, household, chemical and agricultural products extruded sheet and thermoformed containers for food manufacturers, kiwifruit and horticultural products disposable and point-of-sale packaging for the food service sector and injection-moulded components for human and animal health products. [Pg.135]

Moving on to discuss specific market sectors, I thought I would chart the history of the key milestones in the development of animal health natural product drugs. Whilst the intention is that this review should be an objective discussion of important academic and industrial discoveries, as this is very much a personal perspective, it has been difficult not to include a tinge of commercial bias. Therefore, I chose my starting point as 1849. [Pg.46]


See other pages where Animal health industry is mentioned: [Pg.107]    [Pg.106]    [Pg.107]    [Pg.56]    [Pg.333]    [Pg.462]    [Pg.107]    [Pg.106]    [Pg.107]    [Pg.56]    [Pg.333]    [Pg.462]    [Pg.48]    [Pg.459]    [Pg.79]    [Pg.169]    [Pg.207]    [Pg.6]    [Pg.331]    [Pg.484]    [Pg.138]    [Pg.83]    [Pg.221]    [Pg.211]    [Pg.381]    [Pg.326]    [Pg.616]    [Pg.50]    [Pg.241]    [Pg.60]    [Pg.163]    [Pg.233]    [Pg.345]    [Pg.345]    [Pg.201]    [Pg.197]   


SEARCH



Animal health

© 2024 chempedia.info